Re: How is Zenith affected by the RVX top line miss

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Nextblockbuster

Rank: President [?]

Points: 2717 [?]

Votes: 15 Score: 3.8 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: How is Zenith affected by the RVX top line miss

in response to

How is Zenith affected by the RVX top line miss

rocketman2

posted on Sep 30, 2019 07:15PM

since the Zen 3694 is not a blinded trial one can assume by now that Zenith knows if the drug is working or not , i think any deal , ie partnership with a major BP only helps legitimize the science and RVX , We should be hearing more about all trial at the AGM, hopefully something is in the works , sooner the better

4 Recommendations

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply